Unprecedented Body of New Clinical Evidence using the MolecuLight Wound Imaging Platform Demonstrates Improved Clinical Decision-Making and Patient Outcomes TORONTO and SALT LAKE CITY,
/PRNewswire/ MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of elevated bacterial loads in wounds, announces.
New FDA Clearance Illustrates the Utility of the i:X to Reliably DetectClinically Significant Bacteria that Impedes Wound Healing TORONTO, June 29, 2022 /PRNewswire/ MolecuLight Inc.
Results Published in Study Show MolecuLight Fluorescence Point-of-Care Imaging Detected Pseudomonas Aeruginosa (PA) in Wounds with a PPV of 93% finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.